Oct 24, 2024 / 11:30AM GMT
Sijmen de Vries - Pharming Group NV - Chief Executive Officer, Executive Director
Good morning. Good afternoon. Ladies and gentlemen, welcome to our reserve call. I'm happy, I'm here with the introduce my colleagues here, Stephen Toor Chief Commercial Officer and Anurag Relan our Chief Medical Officer and you can welcome on our Chief Financial Officer and we will take you through the results and obviously answer all your questions.
So, but before I do that, I would like to have the next slide and point you to the forward-looking statements. Because during this presentation, we will be making in the usual forward-looking statements which of course, you know, are expressions of our expectations, which can differ significantly, of course from future and future results. So having said that I would like to start with the next slide, you see a slide of my face there and you'll see no doubt the announcement that after '16 years here at the helm, which is actually precisely next week.
I have informed the board of directors that I will not be available for re-election. You know, the company is in
Q3 2024 Pharming Group NV Earnings Call Transcript
Oct 24, 2024
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers